Chunsong Yang

Sichuan University

Papers

1

Total Citations

12

H-Index

1

About

Dr. Chunsong Yang is a leading researcher in pharmaceutical technology and health services, with a primary focus on the safety and efficiency of intravenous (IV) admixture services. Her most notable contribution is a landmark 2023 systematic review on intravenous compounding robots, which has already garnered 12 citations and serves as a critical resource for hospital decision-makers. This work addresses a significant gap in evidence by systematically evaluating the use of robotic systems to automate the compounding of sterile IV medications—a process traditionally prone to human error and contamination risks. By synthesizing data from professional health technology assessments and electronic databases, Dr. Yang provides actionable insights into how robotics can enhance patient safety, reduce medication errors, and optimize pharmacy workflows. Her research bridges the gap between emerging automation technologies and clinical practice, offering a rigorous framework for hospitals considering the adoption of IV compounding robots. With her work increasingly cited by both pharmacy practitioners and health technology assessors, Dr. Yang is establishing herself as a key voice in the modernization of sterile compounding, helping to shape evidence-based policies that improve outcomes for patients and healthcare systems alike.

Research Focus

Key Achievements

1
H-Index
1
Papers
12
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Intravenous compounding robots in pharmacy intravenous admixture services: A systematic review
12 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: Sichuan University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago